<DOC>
	<DOCNO>NCT00659802</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy HMPL-004 patient active mild moderate ulcerative colitis ( UC ) , compare placebo .</brief_summary>
	<brief_title>Phase II Study HMPL-004 Patients With Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Have active confirm mild moderate ulcerative colitis Diagnosed Crohn 's Disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>